Investors

By Dave Muoio 03:23 pm July 17, 2019
Following a major sales bump in the second quarter of 2019, Abbott Laboratories is planning to significantly ramp up manufacturing for its FreeStyle Libre continuous glucose monitoring system, the company shared during an investor’s call this morning. Specifically, the company highlighted a 72.9% increase in organic sales growth during the three-month period, reaching a worldwide total sales...
By Laura Lovett 09:47 am July 17, 2019
This morning DEARhealth, a startup offering artificial intelligence-enabled disease management software, announced that it landed $6.8 million in Series A funding. The new influx of cash was provided by Philips Health Technology Ventures, Vesalius Bio capital lll and Health Innovations.  This news comes just weeks after the startup announced that it is teaming up with pharma giant UCB on a new...
By Dave Muoio 03:20 pm July 16, 2019
The first half of 2019 has been bigger for digital health than any year opening before it, according to a new funding report from Mercom Capital Group. While these conclusions were similar to those of MobiHealthNews and Rock Health, both released earlier this month, Mercom’s count pegged 2019’s to-date funding a bit higher at $5.1 billion raised through 318 deals (2018 saw $4.9 billion from 383...
By Laura Lovett 02:22 pm July 16, 2019
Diabetes management startup Pops! Diabetes Care has scored $6 million in an oversubscribed Series A round. The round was led by 30Ventures with participation from Rise of the Rest Seed Fund and Flying Point Industries.  As part of the deal, 30Ventures Managing Partner George Arida joined the board. This isn’t the first infusion of cash for the startup. In 2017 it raised $1.2 million to bring its...
By Dave Muoio 01:34 pm July 16, 2019
Wave, a subscription app and connected foam cushion for at-home meditation, has launched with $5.65 million in seed funding. CrossLink Capital, Lerer Hippeau Ventures, Collaborative Fund and Ludlow Ventures were named as the company’s backers in this morning’s announcement. WHAT THEY DO The core of Wave’s consumer offering is an app-based service ($9.99 per month, $99.99 for a year) that looks to...

Above photo: Tomoko Inoue, CEO of OMRON Ventures. Credit: OMRON Ventures

By Dean Koh 01:45 am July 16, 2019
With a background in biomedical science and rich experience in medical device venture capital investment, Tomoko Inoue possesses the technical, operational and business knowledge of what makes medtech startups successful – a role perfectly suited for her current role as the CEO of OMRON Ventures.  She believes that in a hyper aging society like Japan, there is a big need for smart infrastructure...
By Dave Muoio 01:41 pm July 15, 2019
This morning Mahmee, a Los Angeles-based platform offering pre- and postpartum support to mothers and providers, announced $3 million in new funding headed by ArlanWasHere Investments. Other participants included Mark Cuban, Serena Williams’ Serena Ventures and Revolution’s Rise of the Rest Seed Fund. WHAT THEY DO Mahmee’s tool works within a provider’s IT system to link a mother and child’s...
By Dave Muoio 09:08 am July 15, 2019
Echelon Fitness Multimedia, maker of Echelon Fit connected spin bikes and on-demand digital workouts, has received an infusion of growth capital from North Castle Partners. The companies declined to specify the size of this investment, but told MobiHealthNews that it brings Echelon’s business to a total value of $100 million. WHAT THEY DO On the surface, Echelon Fit — a standalone entity launched...
By Laura Lovett 02:51 pm July 9, 2019
This morning precision medicine company GNS Healthcare announced a $23 million Series D raise. This latest investment round was led by Cigna Ventures with participation from Amgen Ventures, Celegene, Echo Health Ventures, Alexandria Venture Investments and Gary Loveman, the former CEO of Caesar and division president of Aetna.  WHAT THEY DO The company’s platform, dubbed REFS (Reverse Engineering...

Above: Screengrab of Synyi's website.

By Dean Koh 03:31 am July 9, 2019
Shanghai-based medical AI startup Synyi announced that it has raised RMB 250M ($36.3M) in Series C funding led by Chinese tech giant Tencent. Founded in 2016, Synyi started with Natural Language Processing (NLP) capabilities in the Chinese language and focused on hospitals’ demand for scientific research data, combining AI & HIT to create their first smart analytics platform. To solve the...